Immune cell functions such as phagocytosis and synthesis of immunometabolites, as well as immune cell survival, proliferation and differentiation, largely depend on an adequate availability of glucose by immune cells. During inflammation, the glucose demands of the immune system may increase to amounts similar to those required for high milk yields. Similar metabolic pathways are involved in the adaptation to both lactation and inflammation, including changes in the somatotropic axis and glucocorticoid response, as well as adipokine and cytokine release. They affect (i) cell growth, proliferation and activation, which determines the metabolic activity and thus the glucose demand of the respective cells; (ii) the overall availability of glucose through intake, mobilization and gluconeogenesis; and (iii) glucose uptake and utilization by different tissues. Metabolic adaptation to inflammation and milk synthesis is interconnected. An increased demand of one life function has an impact on the supply and utilization of glucose by competing life functions, including glucose receptor expression, blood flow and oxidation characteristics. In cows with high genetic merits for milk production, changes in the somatotropic axis affecting carbohydrate and lipid metabolism as well as immune functions are profound. The ability to cut down milk synthesis during periods when whole-body demand exceeds the supply is limited. Excessive mobilization and allocation of glucose to the mammary gland are likely to contribute considerably to peripartal immune dysfunction.

The levels of production diseases (PD) and the cow replacement rate are high in dairy farming. They indicate excessive production demands on the cow and a poor state of animal welfare. This is the subject of increasing public debate. The purpose of this study was to assess the effect of production diseases on the economic sustainability of dairy farms. The contributions of individual culled cows to the farm’s economic performance were calculated, based on milk recording and accounting data from 32 farms in Germany. Cows were identified as ‘profit cows’ when they reached their individual ‘break-even point’. Data from milk recordings (yield and indicators for PD) were used to cluster farms by means of a principal component and a cluster analysis. The analysis revealed five clusters of farms. The average proportion of profit cows was 57.5%, 55.6%, 44.1%, 29.4% and 19.5%. Clusters characterized by a high proportion of cows with metabolic problems and high culling and mortality rates had lower proportions of profit cows, somewhat irrespective of the average milk-yield per cow. Changing the perception of PD from considering it as collateral damage to a threat to the farms’ economic viability might foster change processes to reduce production diseases.

Glucose plays a central role in numerous physiological processes in dairy cows related to immune defence and milk production. A lack of glucose impairs both objectives, although to different degrees. A method for the estimation of glucose balance (GB) in dairy cows was developed to assess glucose reserves in the intermediary metabolism. Digestive fluxes of glucogenic carbon were individually estimated via the Systool Web application based on data on body weight (BW), dry matter intake (DMI), and chemical analyses of feedstuffs. Fluxes of endogenous precursors glycerol, alanine and L-lactate and the glucose demand imposed by major glucose-consuming organs were deduced from BW, lactose yield and lactation stage. GB was calculated for 201 lactations (1 to 105 DIM) of 157 cows fed isoenergetic rations. Individual DMI, BW and milk yield were assessed on a daily basis. The results showed that the GB varied greatly between cows and lactation stages. In the first week of lactation, average daily GB reached levels close to zero (3.2 ± 13.5 mol C) and increased as lactation progressed. Most cows risk substantial shortages of glucose for maintenance during the first weeks of lactation. In face of the specific role of glucose for the functional capability of the immune function, the assessment of glucose reserves is a promising measure for the identification of cows at risk of impaired immunocompetence.

Shortages of energy and glucose have been hypothesized to play a key role in the development of and responses to production diseases in dairy cows during early lactation. Given the importance of glucose for immune functions, we used a recently established method for the estimation of glucose balance (GB) to evaluate glucose availability during disease phases. A dataset comprising ration analyses as well as individual daily milk yields (MY), dry matter intake (DMI), body weights, and health records of 417 lactations (298 cows) was used to calculate individual daily GB and energy balance (EB). The magnitude and dynamics of MY, DMI, GB, and EB were evaluated in the weeks before, at, and after diagnoses of inflammatory diseases in different stages of early lactation from week in milk 1 to 15. Diagnoses were categorized as mastitis, claw and leg diseases, and other inflammatory diseases. Mixed linear models with a random intercept and slope term for each lactation were used to evaluate the effect of diagnosis on MY, DMI, GB, and EB while accounting for the background effects of week in milk, parity, season, and year. When unaffected by disease, in general, the GB of cows was close to zero in the first weeks of lactation and increased as lactation progressed. Weekly means of EB were negative throughout all lactation stages investigated. Disease decreased both the input of glucose precursors due to a reduced DMI as well as the output of glucose via milk due to a reduced MY. On average, the decrease in DMI was −1.5 (−1.9 to −1.1) kg and was proportionally higher than the decrease in MY, which averaged −1.0 (−1.4 to −0.6) kg. Mastitis reduced yield less than claw and leg disease or other diseases. On average, GB and EB were reduced by −3.8 (−5.6 to −2.1) mol C and −7.5 (−10.2 to −4.9) MJ in the week of diagnosis. This indicates the need to investigate strategies to increase the availability of glucogenic carbon for immune function during disease in dairy cows.